Skip to content

Illumina ILMN Instruments — Total Revenue

Other product segments

Consumables
$797M+3.8%
Service
$174M+8.1%

Similar metrics at other companies

Quanterix Corporation logo
QTRXInstruments — Total revenues
$4.1M+56.2%
Pacific Biosciences of California logo
PACBInstrument revenue — Total Revenue
$9.72M-11.8%
10x Genomics, Inc. logo
TXGInstruments — Revenue
$11.26M-24.0%
IAR
IARTInstruments — Total Revenues
$47.23M-7.3%
ALM
ALMRInstruments — Revenue
$7.38M+78.0%
TEC
TECHInstruments — Revenue
$27.66M+5.9%

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$26.6B+91.5%
Enterprise value$27.56B+83.6%
P/E31.2×+20.1×
P/S6.1×+2.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's instruments — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's instruments — total revenue?
Illumina (ILMN) reported instruments — total revenue of $120M in Q1 2026.
How has Illumina's instruments — total revenue changed year-over-year?
Illumina's instruments — total revenue increased by 7.1% year-over-year, from $112M to $120M.
What is the long-term trend for Illumina's instruments — total revenue?
Over 4 years (2021 to 2025), Illumina's instruments — total revenue has grown at a -10.5% compound annual growth rate (CAGR), from $752M to $482M.
What does instruments — total revenue mean?
This metric represents the total gross revenue generated from the sale of hardware and sequencing platforms within a specific business segment. It reflects the company's ability to drive adoption of its core technology infrastructure among life science and clinical research customers. Fluctuations in this figure indicate shifts in capital expenditure cycles for laboratory equipment and the overall market demand for high-throughput sequencing capabilities.